Please enable JavaScript to continue using this application.

Compare $COGT vs $MIRM | Chartloom

Compare

$COGT vs $MIRM

Cogent Biosciences Inc · Mirum Pharmaceuticals Inc

COGT

Cogent Biosciences Inc

MIRM

Mirum Pharmaceuticals Inc

Compare $COGT vs $MIRM

Comparing Cogent Biosciences Inc and Mirum Pharmaceuticals Inc

COGTCogent Biosciences Inc

MIRMMirum Pharmaceuticals Inc

COGTCogent Biosciences Inc

Market cap

$5.30B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

24.59x

Rev growth (TTM)

—

YTD performance

-10.8%

52W performance

99.0%

FCF yield

-5.8%

MIRMMirum Pharmaceuticals Inc

Market cap

$5.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.85x

Rev growth (TTM)

44.0%

YTD performance

10.2%

52W performance

18.1%

FCF yield

-5.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

COGT

MIRM

Detailed metrics comparison

COGT

Cogent Biosciences Inc

MIRM

Mirum Pharmaceuticals Inc

Market Cap

COGT$5.30B

MIRM$5.24B

Enterprise Value

COGT$5.34B

MIRM$5.66B

Price

COGT$31.00

MIRM$86.01

P/E Ratio

COGTN/A

MIRMN/A

P/S Ratio

COGT232.42x

MIRM8.49x

EV/Sales

COGT234.24x

MIRM9.16x

EV/EBITDA

COGT0.00x

MIRM2,753.41x

P/B Ratio

COGT10.11x

MIRM22.21x

P/FCF Ratio

COGTN/A

MIRMN/A

EV/FCF

COGT-17.27x

MIRM-21.48x

PEG Ratio

COGTN/A

MIRMN/A

Forward P/E (NTM)

COGTN/A

MIRMN/A

Forward P/S (NTM)

COGT24.59x

MIRM6.85x

Revenue (TTM)

COGT$0

MIRM$618M

Revenue Growth (YoY)

COGTN/A

MIRM44.0%

Forward Rev Growth

COGT2636.5%

MIRM17.0%

Gross Margin (TTM)

COGT0.0%

MIRM81.7%

Operating Margin (TTM)

COGT0.0%

MIRM0.0%

EBITDA Margin (TTM)

COGT0.0%

MIRM-10.6%

Net Margin (TTM)

COGT0.0%

MIRM-139.2%

FCF Margin (TTM)

COGTN/A

MIRM-42.7%

Net Income (TTM)

COGT$-332M

MIRM$-860M

FCF (TTM)

COGT$-309M

MIRM$-264M

EPS (TTM)

COGT-$1.94

MIRM-$13.57

ROE (TTM)

COGT-7257.0%

MIRM-28933.0%

ROA (TTM)

COGT-4865.0%

MIRM-9655.0%

ROIC (TTM)

COGT-5402.0%

MIRM-13639.0%

Cash

COGT$181M

MIRM$331M

Debt

COGT$223M

MIRM$750M

Net Cash/Debt

COGT$-42M

MIRM$-419M

Current Ratio (TTM)

COGT13.57x

MIRM2.86x

Quick Ratio (TTM)

COGT13.36x

MIRM2.62x

Debt/Equity (TTM)

COGT0.42x

MIRM1.28x

Debt/Assets (TTM)

COGT0.0%

MIRM0.0%

Interest Coverage (TTM)

COGTN/A

MIRMN/A

Net Debt/EBITDA (TTM)

COGT0.00x

MIRM0.00x

Beta

COGT0.34

MIRM0.75

52W Performance

COGT99.0%

MIRM18.1%

YTD Performance

COGT-10.8%

MIRM10.2%

% from 52W High

COGT-29.1%

MIRM-33.8%

% from 52W Low

COGT125.0%

MIRM36.0%

Asset Turnover (TTM)

COGT0.36x

MIRM0.69x

FCF Yield (TTM)

COGT-5.8%

MIRM-5.0%

Earnings Yield (TTM)

COGT-6.3%

MIRM-16.4%

Dividend Yield (TTM)

COGTN/A

MIRMN/A

Rule of 40

COGT0.0

MIRM1.3

EV/GP/RG

COGTN/A

MIRM0.45

Ticker research

View COGT research View MIRM research

Metric	COGT Cogent Biosciences Inc	MIRM Mirum Pharmaceuticals Inc
Market & Valuation
Market Cap	$5.30B	$5.24B
Enterprise Value	$5.34B	$5.66B
Price	$31.00	$86.01
P/E Ratio	N/A	N/A
P/S Ratio	232.42x	8.49x
EV/Sales	234.24x	9.16x
EV/EBITDA	0.00x	2,753.41x
P/B Ratio	10.11x	22.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.27x	-21.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	24.59x	6.85x
Revenue & Growth
Revenue (TTM)	$0	$618M
Revenue Growth (YoY)	N/A	44.0%
Forward Rev Growth	2636.5%	17.0%
Profitability
Gross Margin (TTM)	0.0%	81.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-10.6%
Net Margin (TTM)	0.0%	-139.2%
FCF Margin (TTM)	N/A	-42.7%
Net Income (TTM)	$-332M	$-860M
FCF (TTM)	$-309M	$-264M
EPS (TTM)	-$1.94	-$13.57
ROE (TTM)	-7257.0%	-28933.0%
ROA (TTM)	-4865.0%	-9655.0%
ROIC (TTM)	-5402.0%	-13639.0%
Financial Health
Cash	$181M	$331M
Debt	$223M	$750M
Net Cash/Debt	$-42M	$-419M
Current Ratio (TTM)	13.57x	2.86x
Quick Ratio (TTM)	13.36x	2.62x
Debt/Equity (TTM)	0.42x	1.28x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	0.75
52W Performance	99.0%	18.1%
YTD Performance	-10.8%	10.2%
% from 52W High	-29.1%	-33.8%
% from 52W Low	125.0%	36.0%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.69x
FCF Yield (TTM)	-5.8%	-5.0%
Earnings Yield (TTM)	-6.3%	-16.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	1.3
EV/GP/RG	N/A	0.45
Ticker research	View COGT research	View MIRM research

Valuation

P/S Ratio

MIRM

8.49x

COGT

232.42x

EV/FCF

MIRM

-21.48x

COGT

-17.27x

Growth & revenue

Revenue Growth TTM

MIRM

44.0%

Forward Revenue Growth

COGT

2636.5%

MIRM

17.0%

Profitability & performance

Gross Margin

MIRM

81.7%

COGT

0.0%

ROE

COGT

-7257.0%

MIRM

-28933.0%

FCF Yield %

MIRM

-5.0%

COGT

-5.8%

52-Week Performance

COGT

99.0%

MIRM

18.1%

Detailed metrics comparison

COGT

Cogent Biosciences Inc

MIRM

Mirum Pharmaceuticals Inc

Market Cap

COGT$5.30B

MIRM$5.24B

Enterprise Value

COGT$5.34B

MIRM$5.66B

Price

COGT$31.00

MIRM$86.01

P/E Ratio

COGTN/A

MIRMN/A

P/S Ratio

COGT232.42x

MIRM8.49x

EV/Sales

COGT234.24x

MIRM9.16x

EV/EBITDA

COGT0.00x

MIRM2,753.41x

P/B Ratio

COGT10.11x

MIRM22.21x

P/FCF Ratio

COGTN/A

MIRMN/A

EV/FCF

COGT-17.27x

MIRM-21.48x

PEG Ratio

COGTN/A

MIRMN/A

Forward P/E (NTM)

COGTN/A

MIRMN/A

Forward P/S (NTM)

COGT24.59x

MIRM6.85x

Revenue (TTM)

COGT$0

MIRM$618M

Revenue Growth (YoY)

COGTN/A

MIRM44.0%

Forward Rev Growth

COGT2636.5%

MIRM17.0%

Gross Margin (TTM)

COGT0.0%

MIRM81.7%

Operating Margin (TTM)

COGT0.0%

MIRM0.0%

EBITDA Margin (TTM)

COGT0.0%

MIRM-10.6%

Net Margin (TTM)

COGT0.0%

MIRM-139.2%

FCF Margin (TTM)

COGTN/A

MIRM-42.7%

Net Income (TTM)

COGT$-332M

MIRM$-860M

FCF (TTM)

COGT$-309M

MIRM$-264M

EPS (TTM)

COGT-$1.94

MIRM-$13.57

ROE (TTM)

COGT-7257.0%

MIRM-28933.0%

ROA (TTM)

COGT-4865.0%

MIRM-9655.0%

ROIC (TTM)

COGT-5402.0%

MIRM-13639.0%

Cash

COGT$181M

MIRM$331M

Debt

COGT$223M

MIRM$750M

Net Cash/Debt

COGT$-42M

MIRM$-419M

Current Ratio (TTM)

COGT13.57x

MIRM2.86x

Quick Ratio (TTM)

COGT13.36x

MIRM2.62x

Debt/Equity (TTM)

COGT0.42x

MIRM1.28x

Debt/Assets (TTM)

COGT0.0%

MIRM0.0%

Interest Coverage (TTM)

COGTN/A

MIRMN/A

Net Debt/EBITDA (TTM)

COGT0.00x

MIRM0.00x

Beta

COGT0.34

MIRM0.75

52W Performance

COGT99.0%

MIRM18.1%

YTD Performance

COGT-10.8%

MIRM10.2%

% from 52W High

COGT-29.1%

MIRM-33.8%

% from 52W Low

COGT125.0%

MIRM36.0%

Asset Turnover (TTM)

COGT0.36x

MIRM0.69x

FCF Yield (TTM)

COGT-5.8%

MIRM-5.0%

Earnings Yield (TTM)

COGT-6.3%

MIRM-16.4%

Dividend Yield (TTM)

COGTN/A

MIRMN/A

Rule of 40

COGT0.0

MIRM1.3

EV/GP/RG

COGTN/A

MIRM0.45

Ticker research

View COGT research View MIRM research

Metric	COGT Cogent Biosciences Inc	MIRM Mirum Pharmaceuticals Inc
Market & Valuation
Market Cap	$5.30B	$5.24B
Enterprise Value	$5.34B	$5.66B
Price	$31.00	$86.01
P/E Ratio	N/A	N/A
P/S Ratio	232.42x	8.49x
EV/Sales	234.24x	9.16x
EV/EBITDA	0.00x	2,753.41x
P/B Ratio	10.11x	22.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.27x	-21.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	24.59x	6.85x
Revenue & Growth
Revenue (TTM)	$0	$618M
Revenue Growth (YoY)	N/A	44.0%
Forward Rev Growth	2636.5%	17.0%
Profitability
Gross Margin (TTM)	0.0%	81.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-10.6%
Net Margin (TTM)	0.0%	-139.2%
FCF Margin (TTM)	N/A	-42.7%
Net Income (TTM)	$-332M	$-860M
FCF (TTM)	$-309M	$-264M
EPS (TTM)	-$1.94	-$13.57
ROE (TTM)	-7257.0%	-28933.0%
ROA (TTM)	-4865.0%	-9655.0%
ROIC (TTM)	-5402.0%	-13639.0%
Financial Health
Cash	$181M	$331M
Debt	$223M	$750M
Net Cash/Debt	$-42M	$-419M
Current Ratio (TTM)	13.57x	2.86x
Quick Ratio (TTM)	13.36x	2.62x
Debt/Equity (TTM)	0.42x	1.28x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	0.75
52W Performance	99.0%	18.1%
YTD Performance	-10.8%	10.2%
% from 52W High	-29.1%	-33.8%
% from 52W Low	125.0%	36.0%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.69x
FCF Yield (TTM)	-5.8%	-5.0%
Earnings Yield (TTM)	-6.3%	-16.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	1.3
EV/GP/RG	N/A	0.45
Ticker research	View COGT research	View MIRM research